Medtronic Vascular Inc et al v. Boston Scientific Corporation et al, No. 2:09-cv-00028 (E.D. Tex. Feb. 2, 2009)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is plaintiffs Medtroni c Vascular, Inc.’s, Medtronic USA, Inc.’s, Medtronic, Inc.’s, and Medtroni c Vascular Galway, Ltd.’s (co llectively, “Medtronic”) Motion for Severance of Claims for Post-Verdict Ro yalties to Allow for En try of Final Judgment (Docket Entry #277). In this motion, Medtroni c requests the Court to sever Medtronic’s continuing causes of action for post-verdict infringement of U.S. Patent No. 6,210,364 (“the ‘364 Patent”) into a separate case, allowing the Cour t to enter final judgment.